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Background
Prostaglandin (PG) D2 is substantially involved in aller-
gic responses and signals via the seven-transmembrane-
spanning/G protein-coupled receptors, chemoattractant
receptor-homologous molecule expressed on Th2 cells
(CRTH2) and D-type prostanoid (DP) receptor. While
the proinflammatory function of CRTH2 is well recog-
nized and CRTH2 is hence considered as an important
emerging pharmacotherapeutic target, the role of the
DP receptor in mediating the biological effects of PGD2
in allergic inflammation has remained unclear.
Methods
The cross-talk of CRTH2 and DP receptors was investi-
gated using both a recombinant HEK293 cell model and
human eosinophils in Ca
2+ mobilization assays, co-
immunoprecipitation and radioligand binding assays.
Results
We show that CRTH2 and DP receptors modulate each
other’s signalling properties and form CRTH2/DP het-
eromers without altering their ligand-binding capacities.
We find that the DP receptor amplifies the CRTH2-
induced Ca
2+ release from intracellular stores and, coin-
cidentally, forfeits its own signalling potency. Moreover,
desensitization or pharmacological blockade of the DP
receptor hinders CRTH2-mediated signal transduction.
Pharmacological blockade of Gaq/11 proteins abolishes
the Ca
2+ response to both CRTH2 and DP agonists,
while inhibition of Gai proteins selectively attenuates the
CRTH2-mediated response but not the DP signal.
Conclusions
Our data demonstrate the capacity of DP receptors to
amplify the biological response to CRTH2 activation.
Therefore, the CRTH2/DP heteromer may not only
represent a functional signalling unit for PGD2 but also
a potential target for development of heteromer-directed
therapies to treat allergic diseases.
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